Sign in
CompletedNo phase

Assessing the Effects of Robotic Pets on Patients With Dementia in the Acute Care Hospital Setting

Key facts

Who runs it
Sarasota Memorial Health Care System
Where
Sarasota, United StatesSee the site
Trial code
Status
Completed
People taking part
106 people enrolled
Started
2 Jan 2024
Ended
29 Dec 2025
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • Robotic Joy for All™ pet
Record updated
17 March 2026

Who can take part

Age
65 years and older
Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (2)Hide the full registry criteria

Who can take part

  • Patients with:; Dementia indicated in the patient's chart; Admitted to the designated medical-surgical units at Sarasota Memorial Health Care System; Ages 65 and older; NuDESC score will be 0-4 during study enrollment

Who cannot take part

  • Patients who are:; <65 years old; NuDESC score >4 during study enrollment; Patients at risk for alcohol withdrawal or substance abuse withdrawal; Enhanced isolation precautions (c.diff); Presenting with paranoia, hallucinations, or severe agitation

Where in United States

  • Sarasota Memorial Health Care SystemSarasota, United States

About the trial

What the trial wants to find out

Robotic pets can provide a source of affection and companionship for patients. This is especially important as individuals with dementia may receive infrequent visitation from family members if their families struggle with how to cope and communicate with their loved one. Several options such as the "Joy for All™" and "Paro" robotic pets offer a source of companionship that is both interactive and comforting.

Read full original descriptionShow less

Sarasota Memorial Health Care System (SMHCS) researchers are seeking to make companion pets available to patients with dementia to provide them with a supplemental enrichment experience that enhances their overall care and lowers their risk for superimposed delirium. The intervention will consist of providing a robotic pet to the patient within 48 hours of admission, which the patient will keep with them throughout their hospital stay and upon discharge. SMHCS researchers will evaluate the effects of the robotic pet interaction on patient delirium scores, as measured by the Nursing Delirium Screening Scale (Nu-DESC), length of stay, and the use of intravenous psychotropic medications, code greys, falls occurrence, restraint use, and IV dislodgement in patients with mild-to-moderate dementia. The Nu-DESC scale is a short assessment tool, estimated to take approximately 3-5 minutes to complete and is already part of standard care at SMHCS. This tool is used by nursing staff with minimal additional training and shows consistent sensitivity (85.7%) and specificity (86.8%) in detecting delirium. The NuDESC score may be positive in a patient with dementia, since some characteristics of dementia can be similar to delirium. However, patients with dementia are at higher risk for developing delirium, so the NuDESC is a helpful tool for the nurse. A score of 2 or higher is considered screening positive for delirium. For this study, the NuDESC tool will be used as a guideline to assist in the screening of delirium. The patients will have to score a 4 or less to be included in the study. Patients that are scoring >4 will be excluded. Theoretic Framework of Acceptability (TFA) is a questionnaire which will be used to assess health care provider acceptability of the companion animal. This tool is currently not in use at SMHCS, but it will be used as part of this study to assess whether health care providers accept (or reject) the robotic pets as companion animals.

The 2 groups in the trial

  • Robotic PetTreatment being tested

    The intervention group will receive the robotic Joy for All™ pet.

    Treatment: Robotic Joy for All™ pet

  • ControlNo study treatment, for comparison

    Control group will receive the current standard of care, no robotic pet.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
17 March 2026